Steinman D H, Curtin M L, Garland R B, Davidsen S K, Heyman H R, Holms J H, Albert D H, Magoc T J, Nagy I B, Marcotte P A, Li J, Morgan D W, Hutchins C, Summers J B
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064, USA.
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2087-92. doi: 10.1016/s0960-894x(98)00396-5.
A series of succinate-derived hydroxamic acids incorporating a macrocyclic ring were designed, synthesized, and evaluated as inhibitors of matrix metalloproteinases. The inhibitors were designed based on the published X-ray crystal structure of batimastat (1) complexed with human neutrophil collagenase (MMP-8). The synthesized compounds were shown to inhibit selected MMPs in vitro with low nanomolar potency.